Sanara MedTech (SMTI) Stock: Buy, Sell, or Hold?
SMTI - Sanara MedTech Inc. Common Stock
$32.80
-0.08 (-0.24%)
▼
5d:
-1.09%
30d:
-6.55%
90d:
+26.89%
HOLD
MODERATE Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 11, 2026
17d
Get Alerted When SMTI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SMTI trades at premium valuation expecting 11.9% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: SMTI trades at premium valuation expecting 11.9% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$26.29
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$16.32
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SMTI is currently trading at $32.80, which is considered oversold relative to its 30-day fair value range of $33.79 to $35.50. From a valuation perspective, the stock is trading at a premium (Forward PE: 60.7) compared to its historical average (43.4). At these levels, the market is pricing in 11.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SMTI is in a strong uptrend. Immediate support is located at $30.40, while resistance sits at $35.52.
Market Sentiment: SMTI scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SMTI is in a strong uptrend. Immediate support is located at $30.40, while resistance sits at $35.52.
Market Sentiment: SMTI scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$33.79 -
$35.50
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (30/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($35.00)
- NEUTRAL: Trading at premium valuation - market expects 11.9% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$33.79 -
$35.50
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$30.40
Resistance Level
$35.52
Current Trend
Strong Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
60.74
Wall Street Target
$35.00
(+6.7%)
Revenue Growth (YoY)
9.0%
Profit Margin
-29.1%
Valuation Premium vs History
+11.9% premium
PE vs Historical
60.7 vs 43.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+11.9%
(market-implied from PE analysis)
1-Year Target
$36.70
(+12%)
2-Year Target
$41.07
(+25%)
3-Year Target
$45.96
(+40%)
3-Yr Target (if PE normalizes)
(PE: 61→43)
PE COMPRESSION
$32.84
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 60.7, Growth: 170.0%)
$110.70
(+238%)
Base:
(SPY PE: 19.9, Growth: 170.0%)
$36.19
(+10%)
Bear:
(PE: 16.9, Growth: 170.0%)
$30.77
(-6%)
Share & Embed Analysis
Last updated: October 24, 2026 2:04 PM ET
Data refreshes hourly during market hours. Next update: 3:04 PM
Data refreshes hourly during market hours. Next update: 3:04 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SMTI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$479 | 37 SELL |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$83 | 43 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
22 analysts |
$198 | 57 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
17 analysts |
$413 | 37 SELL |
|
STVN
Stevanato Group SpA |
BUY
14 analysts |
$24 | 72 BUY |
